Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Twist Bioscience Corporation (TWST) Tops Q4 EPS by 36c, Offers Guidance
November 18, 2022 7:33 AM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.91), $0.36 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $57.3 million versus the consensus estimate of $56.78 million.
GUIDANCE:
Twist Bioscience Corporation sees Q1 2023 revenue of $54 million, versus the... More



